首页 | 本学科首页   官方微博 | 高级检索  
     

血小板单采术、羟基脲、α-干扰素联合治疗原发性血小板增多症临床分析
引用本文:罗宏山,梁碧玲,郑志惠,陈惠珍,张峰. 血小板单采术、羟基脲、α-干扰素联合治疗原发性血小板增多症临床分析[J]. 热带医学杂志, 2005, 5(4): 487-488
作者姓名:罗宏山  梁碧玲  郑志惠  陈惠珍  张峰
作者单位:中山大学附属第一医院,广州,510080;中山大学附属第一医院,广州,510080;中山大学附属第一医院,广州,510080;中山大学附属第一医院,广州,510080;中山大学附属第一医院,广州,510080
摘    要:目的观察血小板单采术联合羟基脲和α-干扰素治疗原发性血小板增多症(PT)的疗效。方法50例患者确诊后行血小板单采术,同时给予羟基脲和α-干扰素联合治疗。结果血小板单采术后,血小板数显著下降。症状改善。加用羟基脲和α-干扰素联合治疗,血小板数稳定,病情继续缓解。结论联合治疗疗效好、起效快,具有临床推广价值。

关 键 词:原发性血小板增多症  血小板单采术  羟基脲  α-干扰素
文章编号:1672-3619(2005)04-0487-02
修稿时间:2005-01-15

Clinical Analysis of Treating Primary Thrombocythemia with Platelethporesis Together with Hydrea and Alpha-Interferon
LUO Hong-shan,LIANG Bi-Ling,ZHENG Zhi-hui,CHEN Hui-zhen,ZHANG Feng. Clinical Analysis of Treating Primary Thrombocythemia with Platelethporesis Together with Hydrea and Alpha-Interferon[J]. Journal Of Tropical Medicine, 2005, 5(4): 487-488
Authors:LUO Hong-shan  LIANG Bi-Ling  ZHENG Zhi-hui  CHEN Hui-zhen  ZHANG Feng
Abstract:Objective To investigate the therapeutic effect of combined treatment with plateletphoresis, hydrea and alpha-interferon for primary thrombocythemia. Method SO patients with PT were treated with plateletphoresis, hydrea and alpha-interferon. Results, After the plateletphoresis, platelet count decreased progressively and with improvement. With additional treatment of hydrea and alpha-interferon, the platelet count was stable and continuous improvement. Conclusion The combined therapy is effective, quick and should be generally applied in clinic.
Keywords:primary thrombolythemia  plateletphoresis  hydrea  a-interferon  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号